REQUEST A DEMO
Total
USD $0.00
Search more companies

Distribuidora Bioncomedica CIA Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Distribuidora Bioncomedica CIA Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Distribuidora Bioncomedica CIA Ltda imports and distributes medical devices, specializing in urological, gynecologic, cardiovascular, general, and peripheral vascular surgery. They offer a product called ANILLO SURGI - PVA LASIK for post-operative care following endoscopic functional surgery. They also provide import services for unregistered drugs and hard-to-acquire medicines. The company's target market includes those in need of laparoscopic procedures.

Headquarters
Emilio Carrera, Portal del Sol Bldg. , Floor 1
Cuenca; Azuay;

Contact Details: Purchase the Distribuidora Bioncomedica CIA Ltda report to view the information.

Website: http://www.bioncomedica.com

Basic Information
Total Employees:
Purchase the Distribuidora Bioncomedica CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Distribuidora Bioncomedica CIA Ltda report to view the information.
Registered Capital:
Purchase the Distribuidora Bioncomedica CIA Ltda report to view the information.
Incorporation Date:
April 12, 2011
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
99.67%
Purchase this report to view the information.
0.33%
Company Performance
Financial values in the chart are available after Distribuidora Bioncomedica CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
52.28%
Total operating revenue
52.28%
Operating profit (EBIT)
-97.88%
Net Profit (Loss) for the Period
-48.01%
Total assets
-2.81%
Total equity
-28.3%
Operating Profit Margin (ROS)
-62.47%
Net Profit Margin
-0.32%
Return on Equity (ROE)
-2.26%
Debt to Equity Ratio
63.62%
Quick Ratio
0.41%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?